Funding rounds
Every row was found by Firecrawl search and extracted with a schema, with the articles behind it one click away. A check mark means its sources confirmed it.
Every row was found by Firecrawl search and extracted with a schema, with the articles behind it one click away. A check mark means its sources confirmed it.
| Expand | Company | Round | |||
|---|---|---|---|---|---|
An AI operating system for enterprises that helps companies automate workflows, build and deploy AI applications, and coordinate AI agents across their organizations. | Series C Verified against 1 of 20 sources | $550M | 2026-09-02 Sep 2 | No recent discussion | |
A biotech developing re-dosable, all-RNA gene-insertion therapies, including in vivo CAR T, for cancer, autoimmune and severe genetic diseases | Series A Verified against 4 of 9 sources | $56M | 2026-09-02 Sep 2 | No recent discussion | |
Thyme Care enhances the cancer journey with expert oncology navigation and an oncology care team, partnering to improve access, outcomes, and costs. | Series E Verified against 4 of 8 sources | $125M | 2026-09-02 Sep 2 | No recent discussion | |
A fintech focused on foreign exchange and investment services | Seed Developing, 23 sources | $3M | 2026-09-02 Sep 2 | No recent discussion | |
nanoSkunkWorkX sells advanced nanostructured devices for various applications including chips, hydrogen interfaces, and diagnostics. | Seed Verified against 4 sources | $2M | 2026-09-02 Sep 2 | No recent discussion | |
A D2C premium luggage, bags and travel accessories brand | Series C Verified against 4 sources | Rs 170 crore (about $18M) incl. secondary | 2026-09-02 Sep 2 | No recent discussion | |
A physical AI startup building sensing and perception technology for robots | Series C Verified against 1 of 11 sources | $165M | 2026-09-02 Sep 2 | No recent discussion | |
Developer of MaiRa, a blood-based molecular diagnostics platform to identify first-trimester signals of pregnancy complications | Seed Verified against 4 of 6 sources | $17.4M | 2026-09-02 Sep 2 | No recent discussion | |
Immediate provides on-demand payment solutions that allow employees to access their earned wages seamlessly. | Series B Verified against 5 sources | $13M | 2026-09-02 Sep 2 | No recent discussion | |
A German launch services provider | Series A ext. Verified against 4 of 5 sources | $58.1M | 2026-09-02 Sep 2 | No recent discussion | |
A medical technology company using AI-powered, clinically validated software to advance precision diagnosis and treatment of cardiovascular disease | Series D Verified against 4 of 7 sources | $55M | 2026-09-02 Sep 2 | No recent discussion | |
Creedom is an AI growth coach for content creators that analyses Instagram and YouTube performance and recommends what creators should post next. | Seed Verified against 4 of 9 sources | $434K | 2026-09-02 Sep 2 | No recent discussion | |
An AI-driven consumer insights platform used by over 400 enterprises | Series A Verified against 6 sources | $50M | 2026-09-02 Sep 2 | No recent discussion | |
An AI customer-retention startup | Seed Developing, 3 sources | not stated | 2026-09-02 Sep 2 | No recent discussion | |
Egyptian ed-tech platform teaching coding, technology and AI to children and young people. | Seed Verified against 4 of 8 sources | $3M | 2026-09-02 Sep 2 | No recent discussion | |
A generative 3D foundation models company | Series B Verified against 4 of 7 sources | $447.0M | 2026-09-01 Sep 1 | No recent discussion | |
A biotech infrastructure company for oncology trials | Series B Verified against 3 sources | $32M | 2026-09-01 Sep 1 | No recent discussion | |
A robotics healthcare company | Series A Verified against 4 of 7 sources | $14M | 2026-09-01 Sep 1 | No recent discussion | |
A fintech company providing smartphone financing services | Funding round Developing, 3 sources | $30.7M | ~ 2026-09 that month | No recent discussion | |
A Hangzhou-based AI chip developer | Series C Verified against 3 sources | $149M | ~ 2026-09 that month | No recent discussion |
Records are extracted automatically from public reporting and link to their sources. They can contain errors. Report an error